Suppr超能文献

印度糖尿病的患病率、知晓率、治疗率及控制率:一项针对45岁及以上成年人的全国代表性调查。

Prevalence, awareness, treatment, and control of diabetes in India: a nationally representative survey of adults aged 45 years and older.

作者信息

Sekher T V, Flood David, Green Hunter, Hu Peifeng, Ali Mohammed K, Shete Ashwini, Pedgaonkar Sarang, Langa Kenneth M, Crimmins Eileen M, Bloom David E, Lee Jinkook

机构信息

International Institute for Population Sciences, Mumbai, India.

Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA; Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, MI, USA.

出版信息

Lancet Glob Health. 2025 Sep;13(9):e1543-e1552. doi: 10.1016/S2214-109X(23)00502-8. Epub 2025 Aug 7.

Abstract

BACKGROUND

India is a country of 1·4 billion people that contributes to much of the global diabetes burden. Updated evidence on the state of the diabetes epidemic among middle-aged and older adults is imperative given that the risk of diabetes increases with age and that clinical and public health interventions can prevent diabetes complications. We aimed to estimate the prevalence, awareness, treatment, and control of diabetes in a nationally representative and state-representative sample of Indians aged 45 years and older.

METHODS

We conducted a cross-sectional, nationally representative survey of adults in India aged 45 years and older and their spouses from 2017 to 2019. Our sample included 57 810 individuals and their spouses from 36 states and union territories, reflecting a representative sample of India as a nation and of each state and union territory. Participants had available data on glycated haemoglobin (HbA) measurement and non-missing information on diabetes diagnosis, household economic status, and BMI. Spouses younger than 45 years were excluded from the analysis. Our primary outcomes were diabetes prevalence and health service indicators recommended by WHO. Diabetes prevalence was defined as individuals self-reporting a previous diabetes diagnosis or having HbA of 6·5% or higher. Available data did not allow the identification of type 1 versus type 2 diabetes. Diabetes health service indicators were based on four core metrics recommended by WHO: (1) proportion diagnosed out of all individuals with diabetes (awareness) and, out of individuals with diagnosed diabetes, (2) proportion with glycaemic control (measured HbA <7·0%), (3) proportion with blood pressure control (measured blood pressure <140/90 mm Hg), and (4) proportion self-reporting use of lipid-lowering medications. Outcomes were assessed in the national sample; by state and union territory; and across individual-level characteristics of age, sex, rural versus urban area of residence, education, economic status, and BMI.

FINDINGS

Diabetes prevalence among adults aged 45 years and older in India was 19·8% (95% CI 19·4-20·2), which amounted to 50·4 million people (49·4-51·4). Prevalence among men and women was similar (men, 19·6% [95% CI 19·0-20·2] and women, 20·1% [19·5-20·6]). Urban diabetes prevalence (30·0% [95% CI 29·1-30·8]) was approximately twice as high as rural prevalence (15·0% [14·6-15·5]). States with higher levels of economic development tended to have greater age-standardised prevalence (standardised regression coefficient for gross domestic product per capita 0·65 [95% CI 0·45-0·85]). Overall, 60·1% (59·0-61·2) of individuals were aware of their diabetes. Of individuals with diagnosed diabetes, 45·7% (44·3-47·2) achieved glycaemic control, 58·9% (57·5-60·4) achieved blood pressure control, and 6·4% (5·8-7·2) were taking a lipid-lowering medication.

INTERPRETATION

Our findings emphasise the urgent need to scale up policies to better prevent, detect, manage, and control diabetes among middle-aged and older adults in India.

FUNDING

US National Institute on Aging; Ministry of Health and Family Welfare, Government of India.

摘要

背景

印度是一个拥有14亿人口的国家,在全球糖尿病负担中占很大比例。鉴于糖尿病风险随年龄增长而增加,且临床和公共卫生干预措施可预防糖尿病并发症,因此迫切需要有关中老年人群糖尿病流行状况的最新证据。我们旨在估计印度45岁及以上具有全国代表性和邦代表性样本中糖尿病的患病率、知晓率、治疗率和控制率。

方法

我们在2017年至2019年对印度45岁及以上的成年人及其配偶进行了一项全国代表性的横断面调查。我们的样本包括来自36个邦和中央直辖区的57810名个体及其配偶,反映了印度全国以及每个邦和中央直辖区的代表性样本。参与者有糖化血红蛋白(HbA)测量数据,且在糖尿病诊断、家庭经济状况和体重指数方面没有缺失信息。45岁以下的配偶被排除在分析之外。我们的主要结局是糖尿病患病率和世界卫生组织推荐的卫生服务指标。糖尿病患病率定义为自我报告曾被诊断患有糖尿病或糖化血红蛋白水平达到6.5%或更高的个体。现有数据无法区分1型糖尿病和2型糖尿病。糖尿病卫生服务指标基于世界卫生组织推荐的四个核心指标:(1)所有糖尿病患者中被诊断出的比例(知晓率),以及在已诊断糖尿病患者中,(2)血糖得到控制的比例(测量的糖化血红蛋白<7.0%),(3)血压得到控制的比例(测量的血压<140/90 mmHg),以及(4)自我报告使用降脂药物的比例。在全国样本中评估结局;按邦和中央直辖区;以及根据年龄、性别、城乡居住地区、教育程度、经济状况和体重指数等个体特征进行评估。

结果

印度45岁及以上成年人的糖尿病患病率为19.8%(95%置信区间19.4 - 20.2),即5040万人(4940 - 5140万)。男性和女性的患病率相似(男性为19.6%[95%置信区间19.0 - 20.2],女性为20.1%[19.5 - 20.6])。城市糖尿病患病率(30.0%[95%置信区间29.1 - 30.8])约为农村患病率(15.0%[14.6 - 15.5])的两倍。经济发展水平较高的邦往往年龄标准化患病率更高(人均国内生产总值的标准化回归系数为0.65[95%置信区间0.45 - 0.85])。总体而言,60.1%(59.0 - 61.2)的个体知晓自己患有糖尿病。在已诊断糖尿病的个体中,45.7%(44.3 - 47.2)实现了血糖控制,58.9%(57.5 - 60.4)实现了血压控制,6.4%(5.8 - 7.2)正在服用降脂药物。

解读

我们的研究结果强调了迫切需要扩大政策规模,以更好地预防、检测、管理和控制印度中老年人群中的糖尿病。

资金来源

美国国立衰老研究所;印度政府卫生和家庭福利部。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1c7/12397963/d115d4a2b539/nihms-2105996-f0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验